IBDEI0BR ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14915,1,3,0)
 ;;=3^Mild Neurocog D/O d/t PARKINSON'S DISEASE
 ;;^UTILITY(U,$J,358.3,14915,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,14915,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,14916,0)
 ;;=A81.9^^45^657^71
 ;;^UTILITY(U,$J,358.3,14916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14916,1,3,0)
 ;;=3^Prion Disease
 ;;^UTILITY(U,$J,358.3,14916,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,14916,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,14917,0)
 ;;=F02.81^^45^657^32
 ;;^UTILITY(U,$J,358.3,14917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14917,1,3,0)
 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,14917,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,14917,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,14918,0)
 ;;=F02.80^^45^657^33
 ;;^UTILITY(U,$J,358.3,14918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14918,1,3,0)
 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,14918,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,14918,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,14919,0)
 ;;=G31.84^^45^657^63
 ;;^UTILITY(U,$J,358.3,14919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14919,1,3,0)
 ;;=3^Mild Neurocog D/O d/t PRION DISEASE
 ;;^UTILITY(U,$J,358.3,14919,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,14919,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,14920,0)
 ;;=S06.2X9S^^45^657^74
 ;;^UTILITY(U,$J,358.3,14920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14920,1,3,0)
 ;;=3^TRAUMATIC BRAIN INJURY,Diffuse w/ Unspec Duration of LOC,Sequela
 ;;^UTILITY(U,$J,358.3,14920,1,4,0)
 ;;=4^S06.2X9S
 ;;^UTILITY(U,$J,358.3,14920,2)
 ;;=^5020755
 ;;^UTILITY(U,$J,358.3,14921,0)
 ;;=F02.81^^45^657^50
 ;;^UTILITY(U,$J,358.3,14921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14921,1,3,0)
 ;;=3^Major Neurocog D/O d/t TBI w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,14921,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,14921,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,14922,0)
 ;;=F02.80^^45^657^51
 ;;^UTILITY(U,$J,358.3,14922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14922,1,3,0)
 ;;=3^Major Neurocog D/O d/t TBI w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,14922,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,14922,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,14923,0)
 ;;=G31.84^^45^657^64
 ;;^UTILITY(U,$J,358.3,14923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14923,1,3,0)
 ;;=3^Mild Neurocog D/O d/t TBI
 ;;^UTILITY(U,$J,358.3,14923,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,14923,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,14924,0)
 ;;=F01.51^^45^657^48
 ;;^UTILITY(U,$J,358.3,14924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14924,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,14924,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,14924,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,14925,0)
 ;;=F01.50^^45^657^49
 ;;^UTILITY(U,$J,358.3,14925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14925,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,14925,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,14925,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,14926,0)
 ;;=G31.84^^45^657^65
 ;;^UTILITY(U,$J,358.3,14926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14926,1,3,0)
 ;;=3^Mild Neurocog D/O d/t VASCULAR DISEASE
 ;;^UTILITY(U,$J,358.3,14926,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,14926,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,14927,0)
 ;;=R41.9^^45^657^68
 ;;^UTILITY(U,$J,358.3,14927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14927,1,3,0)
 ;;=3^Neurocognitive Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,14927,1,4,0)
 ;;=4^R41.9
 ;;^UTILITY(U,$J,358.3,14927,2)
 ;;=^5019449
 ;;^UTILITY(U,$J,358.3,14928,0)
 ;;=F06.31^^45^658^1
 ;;^UTILITY(U,$J,358.3,14928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14928,1,3,0)
 ;;=3^Depressive Disorder d/t Another Med Cond w/ Depressive Features
 ;;^UTILITY(U,$J,358.3,14928,1,4,0)
 ;;=4^F06.31
 ;;^UTILITY(U,$J,358.3,14928,2)
 ;;=^5003057
 ;;^UTILITY(U,$J,358.3,14929,0)
 ;;=F06.32^^45^658^2
 ;;^UTILITY(U,$J,358.3,14929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14929,1,3,0)
 ;;=3^Depressive Disorder d/t Another Med Cond w/ Major Depressive-Like Episode
 ;;^UTILITY(U,$J,358.3,14929,1,4,0)
 ;;=4^F06.32
 ;;^UTILITY(U,$J,358.3,14929,2)
 ;;=^5003058
 ;;^UTILITY(U,$J,358.3,14930,0)
 ;;=F32.9^^45^658^20
 ;;^UTILITY(U,$J,358.3,14930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14930,1,3,0)
 ;;=3^MDD,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,14930,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,14930,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,14931,0)
 ;;=F32.0^^45^658^17
 ;;^UTILITY(U,$J,358.3,14931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14931,1,3,0)
 ;;=3^MDD,Single Episode,Mild
 ;;^UTILITY(U,$J,358.3,14931,1,4,0)
 ;;=4^F32.0
 ;;^UTILITY(U,$J,358.3,14931,2)
 ;;=^5003521
 ;;^UTILITY(U,$J,358.3,14932,0)
 ;;=F32.1^^45^658^18
 ;;^UTILITY(U,$J,358.3,14932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14932,1,3,0)
 ;;=3^MDD,Single Episode,Moderate
 ;;^UTILITY(U,$J,358.3,14932,1,4,0)
 ;;=4^F32.1
 ;;^UTILITY(U,$J,358.3,14932,2)
 ;;=^5003522
 ;;^UTILITY(U,$J,358.3,14933,0)
 ;;=F32.2^^45^658^19
 ;;^UTILITY(U,$J,358.3,14933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14933,1,3,0)
 ;;=3^MDD,Single Episode,Severe
 ;;^UTILITY(U,$J,358.3,14933,1,4,0)
 ;;=4^F32.2
 ;;^UTILITY(U,$J,358.3,14933,2)
 ;;=^5003523
 ;;^UTILITY(U,$J,358.3,14934,0)
 ;;=F32.3^^45^658^14
 ;;^UTILITY(U,$J,358.3,14934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14934,1,3,0)
 ;;=3^MDD,Single Episode w Psychotic Features
 ;;^UTILITY(U,$J,358.3,14934,1,4,0)
 ;;=4^F32.3
 ;;^UTILITY(U,$J,358.3,14934,2)
 ;;=^5003524
 ;;^UTILITY(U,$J,358.3,14935,0)
 ;;=F32.4^^45^658^16
 ;;^UTILITY(U,$J,358.3,14935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14935,1,3,0)
 ;;=3^MDD,Single Episode,In Partial Remission
 ;;^UTILITY(U,$J,358.3,14935,1,4,0)
 ;;=4^F32.4
 ;;^UTILITY(U,$J,358.3,14935,2)
 ;;=^5003525
 ;;^UTILITY(U,$J,358.3,14936,0)
 ;;=F32.5^^45^658^15
 ;;^UTILITY(U,$J,358.3,14936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14936,1,3,0)
 ;;=3^MDD,Single Episode,In Full Remission
 ;;^UTILITY(U,$J,358.3,14936,1,4,0)
 ;;=4^F32.5
 ;;^UTILITY(U,$J,358.3,14936,2)
 ;;=^5003526
 ;;^UTILITY(U,$J,358.3,14937,0)
 ;;=F33.9^^45^658^13
 ;;^UTILITY(U,$J,358.3,14937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14937,1,3,0)
 ;;=3^MDD,Recurrent Episode,Unspec
 ;;^UTILITY(U,$J,358.3,14937,1,4,0)
 ;;=4^F33.9
 ;;^UTILITY(U,$J,358.3,14937,2)
 ;;=^5003537
 ;;^UTILITY(U,$J,358.3,14938,0)
 ;;=F33.0^^45^658^10
 ;;^UTILITY(U,$J,358.3,14938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14938,1,3,0)
 ;;=3^MDD,Recurrent Episode,Mild
 ;;^UTILITY(U,$J,358.3,14938,1,4,0)
 ;;=4^F33.0
 ;;^UTILITY(U,$J,358.3,14938,2)
 ;;=^5003529
 ;;^UTILITY(U,$J,358.3,14939,0)
 ;;=F33.1^^45^658^11
 ;;^UTILITY(U,$J,358.3,14939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14939,1,3,0)
 ;;=3^MDD,Recurrent Episode,Moderate
 ;;^UTILITY(U,$J,358.3,14939,1,4,0)
 ;;=4^F33.1
 ;;^UTILITY(U,$J,358.3,14939,2)
 ;;=^5003530
 ;;^UTILITY(U,$J,358.3,14940,0)
 ;;=F33.2^^45^658^12
 ;;^UTILITY(U,$J,358.3,14940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14940,1,3,0)
 ;;=3^MDD,Recurrent Episode,Severe
 ;;^UTILITY(U,$J,358.3,14940,1,4,0)
 ;;=4^F33.2
 ;;^UTILITY(U,$J,358.3,14940,2)
 ;;=^5003531
 ;;^UTILITY(U,$J,358.3,14941,0)
 ;;=F33.3^^45^658^7
 ;;^UTILITY(U,$J,358.3,14941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14941,1,3,0)
 ;;=3^MDD,Recurrent Episode w/ Psychotic Features
 ;;^UTILITY(U,$J,358.3,14941,1,4,0)
 ;;=4^F33.3
 ;;^UTILITY(U,$J,358.3,14941,2)
 ;;=^5003532
 ;;^UTILITY(U,$J,358.3,14942,0)
 ;;=F33.41^^45^658^9
 ;;^UTILITY(U,$J,358.3,14942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14942,1,3,0)
 ;;=3^MDD,Recurrent Episode,In Partial Remission
 ;;^UTILITY(U,$J,358.3,14942,1,4,0)
 ;;=4^F33.41
 ;;^UTILITY(U,$J,358.3,14942,2)
 ;;=^5003534
 ;;^UTILITY(U,$J,358.3,14943,0)
 ;;=F33.42^^45^658^8
 ;;^UTILITY(U,$J,358.3,14943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14943,1,3,0)
 ;;=3^MDD,Recurrent Episode,In Full Remission
 ;;^UTILITY(U,$J,358.3,14943,1,4,0)
 ;;=4^F33.42
 ;;^UTILITY(U,$J,358.3,14943,2)
 ;;=^5003535
 ;;^UTILITY(U,$J,358.3,14944,0)
 ;;=F34.8^^45^658^6
 ;;^UTILITY(U,$J,358.3,14944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14944,1,3,0)
 ;;=3^Disruptive Mood Dysregulation Disorder
 ;;^UTILITY(U,$J,358.3,14944,1,4,0)
 ;;=4^F34.8
 ;;^UTILITY(U,$J,358.3,14944,2)
 ;;=^5003539
 ;;^UTILITY(U,$J,358.3,14945,0)
 ;;=F34.1^^45^658^21
 ;;^UTILITY(U,$J,358.3,14945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14945,1,3,0)
 ;;=3^Persistent Depressive Disorder (Dysthmia)
 ;;^UTILITY(U,$J,358.3,14945,1,4,0)
 ;;=4^F34.1
 ;;^UTILITY(U,$J,358.3,14945,2)
 ;;=^331913
 ;;^UTILITY(U,$J,358.3,14946,0)
 ;;=N94.3^^45^658^22
 ;;^UTILITY(U,$J,358.3,14946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14946,1,3,0)
 ;;=3^Premenstrual Dysphoric Disorder
 ;;^UTILITY(U,$J,358.3,14946,1,4,0)
 ;;=4^N94.3
 ;;^UTILITY(U,$J,358.3,14946,2)
 ;;=^5015919
 ;;^UTILITY(U,$J,358.3,14947,0)
 ;;=F06.34^^45^658^3
 ;;^UTILITY(U,$J,358.3,14947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14947,1,3,0)
 ;;=3^Depressive Disorder d/t Another Med Cond w/ Mixed Features,Unsp
 ;;^UTILITY(U,$J,358.3,14947,1,4,0)
 ;;=4^F06.34
 ;;^UTILITY(U,$J,358.3,14947,2)
 ;;=^5003060
 ;;^UTILITY(U,$J,358.3,14948,0)
 ;;=F32.8^^45^658^4
 ;;^UTILITY(U,$J,358.3,14948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14948,1,3,0)
 ;;=3^Depressive Disorder,Other Specified
 ;;^UTILITY(U,$J,358.3,14948,1,4,0)
 ;;=4^F32.8
 ;;^UTILITY(U,$J,358.3,14948,2)
 ;;=^5003527
 ;;^UTILITY(U,$J,358.3,14949,0)
 ;;=F32.9^^45^658^5
 ;;^UTILITY(U,$J,358.3,14949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14949,1,3,0)
 ;;=3^Depressive Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,14949,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,14949,2)
 ;;=^5003528
